Zoonotic diseases, or zoonoses, are on the rise. That may first bring to mind exotic diseases like Ebola, but the reality is that many zoonotic infections happen closer to home, often during everyday activities.
In 2018, we saw an outbreak of psittacosis in poultry plant workers, drug-resistant brucellosis linked to drinking raw (unpasteurized) milk, dog lick–related Capnocytophaga infections, and Salmonella infections linked to pet guinea pigs, hedgehogs, and backyard poultry. These were among many other illnesses and outbreaks caused by contact with a range of animals and other vectors like mosquitos and ticks.
The Vaccine Group aims to commercialise new vaccine platforms for the development of vaccines for use in infection control and for a rapid response to pathogens which unpredictably cross the species barrier and pose a significant threat to human health. As at 27th March 2019, Frontier IP Group Plc (LON:FIPP) have a 19.2% holding in The Vaccine Group.